14-33950611-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022073.4(EGLN3):āc.142A>Gā(p.Lys48Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022073.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGLN3 | NM_022073.4 | c.142A>G | p.Lys48Glu | missense_variant | 1/5 | ENST00000250457.9 | |
EGLN3 | NM_001308103.2 | c.75+67A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGLN3 | ENST00000250457.9 | c.142A>G | p.Lys48Glu | missense_variant | 1/5 | 1 | NM_022073.4 | P1 | |
EGLN3 | ENST00000553215.5 | c.75+67A>G | intron_variant | 1 | |||||
EGLN3 | ENST00000547327.2 | c.142A>G | p.Lys48Glu | missense_variant | 1/1 | ||||
EGLN3 | ENST00000487915.6 | c.4-19396A>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248146Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134732
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461434Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727054
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 08, 2024 | The c.142A>G (p.K48E) alteration is located in exon 1 (coding exon 1) of the EGLN3 gene. This alteration results from a A to G substitution at nucleotide position 142, causing the lysine (K) at amino acid position 48 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at